We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

184 hedge funds and large institutions have $1.02B invested in Natus Medical Inc in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 57 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $6.39M | Put options by funds: $2.84M

26% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 57

14% less funds holding

Funds holding: 214184 (-30)

16% less capital invested

Capital invested by funds: $1.22B → $1.02B (-$197M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

47% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 57

Holders
184
Holders Change
-30
Holders Change %
-14.02%
% of All Funds
4.22%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
30
Increased
72
Reduced
57
Closed
57
Calls
$6.39M
Puts
$2.84M
Net Calls
+$3.55M
Net Calls Change
+$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$8.54M +$2.94M +92,956 +58%
Ameriprise
27
Ameriprise
Minnesota
$7.91M +$352K +11,112 +5%
JP Morgan Chase
28
JP Morgan Chase
New York
$7.6M +$738K +23,315 +12%
BCM
29
Beddow Capital Management
Wyoming
$7.2M +$332K +10,480 +5%
Deutsche Bank
30
Deutsche Bank
Germany
$6.97M +$1.43M +45,315 +28%
HAM
31
Hillcrest Asset Management
Texas
$6.83M -$1.16M -36,577 -15%
WCM Investment Management
32
WCM Investment Management
California
$6.71M -$2.17M -68,564 -26%
Wells Fargo
33
Wells Fargo
California
$6.65M +$1.65M +52,010 +36%
Invesco
34
Invesco
Georgia
$6.58M +$2.85M +90,099 +85%
CI
35
Cambiar Investors
Colorado
$6.3M -$1.51M -47,666 -20%
Renaissance Technologies
36
Renaissance Technologies
New York
$5.58M -$326K -10,300 -6%
Charles Schwab
37
Charles Schwab
California
$5.39M +$326K +10,289 +7%
SO
38
STRS Ohio
Ohio
$4.71M +$949K +30,000 +27%
Goldman Sachs
39
Goldman Sachs
New York
$4.51M +$768K +24,259 +22%
PP
40
PDT Partners
New York
$4.33M +$4.08M +128,800 New
HIMCH
41
Hartford Investment Management Co (HIMCO)
Connecticut
$4.11M -$1.48M -46,618 -28%
BC
42
Broadfin Capital
New York
$3.82M -$2.88M -90,874 -44%
Barclays
43
Barclays
United Kingdom
$3.48M +$1.82M +57,540 +125%
Nordea Investment Management
44
Nordea Investment Management
Sweden
$3.37M +$1.14M +36,110 +56%
KCM
45
Kennedy Capital Management
Missouri
$3.08M -$21.4K -677 -0.7%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$2.82M -$162K -5,129 -6%
QI
47
QS Investors
New York
$2.77M -$180K -5,697 -6%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$2.63M +$103K +3,249 +4%
Morgan Stanley
49
Morgan Stanley
New York
$2.62M -$676K -21,355 -22%
New York State Teachers Retirement System (NYSTRS)
50
New York State Teachers Retirement System (NYSTRS)
New York
$2.59M

NTUS Hedge Fund Activity: Q1 2018 in Review

184 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q1 2018, worth a combined $1.02B — down 16% from $1.22B a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of NTUS and 30 opened new positions — a net loss of 27 holders — while 57 trimmed existing stakes and 72 added.

The largest buyer was Voce Capital Management, opening a new position worth an estimated $20.9M. The largest seller was Daruma Capital Management, exiting entirely with an estimated $49.5M sold.

  • 184 institutional investors held Natus Medical Inc (NTUS) as of Q1 2018, down from 214 in Q4 2017.
  • Funds reported $1.02B of Natus Medical Inc stock for Q1 2018, down 16% quarter-over-quarter.
  • 30 funds opened new Natus Medical Inc positions in Q1 2018 and 57 closed out, a net change of -27 holders.
  • The largest Natus Medical Inc buyer in Q1 2018 was Voce Capital Management, an estimated $20.9M added.
  • The largest Natus Medical Inc seller in Q1 2018 was Daruma Capital Management, an estimated $49.5M sold.

Based on aggregated 13F filings for Q1 2018.